GlassScriptPhysician profile
Marie B Frando
NPI 1629380183
$7,018.59
in general payments reported to CMS, 2019-2025
39 companies · $1,778 in 2025
The $1,778 reported for 2025 was more than what 92% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $849 · 2020: $405 · 2021: $574 · 2022: $1,344 · 2023: $961 · 2024: $1,107 · 2025: $1,778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,846.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,538.05 | 2022-2025 | |
| Merz Pharmaceuticals, LLC | $1,374.70 | 2021-2025 | Xeomin |
| Teva Pharmaceuticals USA, INC. | $444.21 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Ipsen Biopharmaceuticals, INC | $431.28 | 2019-2025 | Dysport |
| Neurocrine Biosciences, INC. | $416.03 | 2019-2025 | Ingrezza |
| Collegium Pharmaceutical, INC. | $297.89 | 2019-2021 | |
| Piramal Critical Care | $289.81 | 2019-2025 | |
| Merz North America, INC. | $209.92 | 2019-2020 | |
| Saol Therapeutics INC. | $157.04 | 2019-2020 | |
| Globus Medical, INC. | $147.36 | 2025 | Excelsius Gps |
| Amgen INC. | $145.43 | 2020-2022 | |
| Microtransponder, INC. | $144.17 | 2023 | |
| Scilex Pharmaceuticals INC. | $114.25 | 2019-2023 | Ztlido |
| Novartis Pharmaceuticals Corporation | $108.59 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $98.17 | 2019-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Frando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.